Home LiteratureArticle Details
PMID: 2809510 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.

The Journal of experimental medicine ·Vol. 170 ·No. 5 ·1989-11-01 ·Pages 1627-33

Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, Lee AT, Kuo GC, Allison AC, Lowry SF

Abstract

Cytokines secreted in response to invading micro-organisms are important mediators of detrimental hemodynamic and metabolic changes in the host. To test whether cachectin/TNF plays a role in triggering release of other cytokines in the setting of infection, anesthetized baboons were passively immunized against systemic cachectin/TNF before infusion of a LD100 dose of live Escherichia coli. Bacteremia led to significant increases in circulating levels of cachectin/TNF, IL-1 beta, and IL-6. Although bacterial endotoxin/lipopolysaccharide is a potent stimulus for the synthesis and release of IL-1 and IL-6 in vitro, specific neutralization of cachectin/TNF in vivo with mAb pretreatment significantly attenuated both the IL-1 beta and the IL-6 responses despite fulminant overwhelming bacteremia. These data suggest that cachectin/TNF is essential for the initiation or amplification of IL-1 and IL-6 release during lethal gram-negative septic shock syndrome.

MeSH Terms
Animals Immunization, Passive Interleukin-1/metabolism Interleukin-6/metabolism Papio Sepsis/blood,physiopathology Shock, Septic/blood,physiopathology Tumor Necrosis Factor-alpha/immunology,physiology
Chemicals
Interleukin-1 Interleukin-6 Tumor Necrosis Factor-alpha
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Fong Y
Department of Surgery, New York Hospital, Cornell Medical Center, New York 10021.
Tracey K J
Moldawer L L
Hesse D G
Manogue K B
Kenney J S
Lee A T
Kuo G C
Allison A C
Lowry S F
References (25)
25 references, click to expand
  1. Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice.
    J Exp Med. 1988 Jun 1;167(6):1987-92 PMID: 3290384
  2. Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose.
    Lancet. 1957 Aug 24;273(6991):368-70 PMID: 13464070
  3. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha.
    Eur J Immunol. 1988 Aug;18(8):1259-64 PMID: 3138137
  4. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
    J Exp Med. 1989 Jan 1;169(1):333-8 PMID: 2783334
  5. Response of the subhuman primate in gram-negative septicemia induced by live Escherichia coli.
    Surg Gynecol Obstet. 1971 Mar;132(3):469-77 PMID: 4993679
  6. A peroxidase-coupled method for the colorimetric determination of serum triglycerides.
    Clin Chem. 1983 Mar;29(3):538-42 PMID: 6825269
  7. On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice.
    J Immunol. 1983 Dec;131(6):2895-902 PMID: 6358356
  8. Human tumor necrosis factor. Production, purification, and characterization.
    J Biol Chem. 1985 Feb 25;260(4):2345-54 PMID: 3871770
  9. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs.
    Nature. 1985 Jun 20-26;315(6021):641-7 PMID: 2989698
  10. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
    Science. 1985 Aug 30;229(4716):869-71 PMID: 3895437
  11. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
    J Exp Med. 1986 Jun 1;163(6):1433-50 PMID: 3486936
  12. Shock and tissue injury induced by recombinant human cachectin.
    Science. 1986 Oct 24;234(4775):470-4 PMID: 3764421
  13. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.
    Lancet. 1987 Feb 14;1(8529):355-7 PMID: 2880163
  14. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.
    Lab Invest. 1987 Mar;56(3):234-48 PMID: 3029503
  15. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.
    Surg Gynecol Obstet. 1987 May;164(5):415-22 PMID: 3576418
  16. Monoclonal antibodies to human recombinant interleukin 1 (IL 1)beta: quantitation of IL 1 beta and inhibition of biological activity.
    J Immunol. 1987 Jun 15;138(12):4236-42 PMID: 2438338
  17. Production of hybridoma growth factor by human monocytes.
    Eur J Immunol. 1987 Oct;17(10):1411-6 PMID: 3500054
  18. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.
    Nature. 1987 Dec 17-23;330(6149):662-4 PMID: 3317066
  19. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.
    J Clin Invest. 1988 Jun;81(6):1925-37 PMID: 3384955
  20. Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection.
    J Immunol. 1989 Feb 1;142(3):948-53 PMID: 2536416
  21. Interleukin-1 and its biologically related cytokines.
    Adv Immunol. 1989;44:153-205 PMID: 2466396
  22. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins.
    Am J Physiol. 1989 Mar;256(3 Pt 2):R659-65 PMID: 2784290
  23. Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man.
    J Immunol. 1989 Apr 1;142(7):2321-4 PMID: 2784459
  24. Cachectin/tumour necrosis factor.
    Lancet. 1989 May 20;1(8647):1122-6 PMID: 2566060
  25. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.
    N Engl J Med. 1988 Aug 18;319(7):397-400 PMID: 3135497
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1989-11-01
Pages
1627-33
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2189514
Subset
IM
Grants
NIGMS NIH HHS · GM-34695 · United States
NIGMS NIH HHS · GM-40586 · United States
NIGMS NIH HHS · KO4GM-00505 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com